to view the full document.
throbber
Case 2:20-cv-03754-JMV-JBC Document 18 Filed 03/22/21 Page 1 of 23 PageID: 1498
`
`Not for Publication
`
`
`
`
`UNITED STATES DISTRICT COURT
`DISTRICT OF NEW JERSEY
`
`Civil Action No. 20-3754
`
`OPINION
`
`
`
`
`
`
`
`SCHWAB CAPITAL TRUST on behalf of its
`series SCHWAB TOTAL STOCK MARKET
`INDEX FUND, SCHWAB HEALTH CARE
`FUND, SCHWAB DIVIDEND EQUITY FUND,
`SCHWAB LARGE-CAP GROWTH FUND,
`SCHWAB S&P 500 INDEX FUND, SCHWAB
`CORE EQUITY FUND, SCHWAB HEDGED
`EQUITY FUND, SCHWAB U.S. LARGE-CAP
`GROWTH INDEX FUND, and SCHWAB
`FUNDAMENTAL US LARGE COMPANY
`INDEX FUND; et al.;
`
`
`Plaintiffs;
`
`v.
`
`CELGENE CORPORATION; et al.;
`
`
`Defendants.
`
`
`
`
`John Michael Vazquez, U.S.D.J.
`
`
`
`Plaintiffs filed this matter after deciding not to participate as a class member in In re
`
`Celgene Corporation Securities Litigation, Civil Action No. 18-4772 (the “Class Action”), a class
`
`action presently pending before this Court. Plaintiffs in both matters allege that Celgene
`
`Corporation (“Celgene”) and several of its officers and/or employees engaged in fraud under
`
`Section 10(b) and Rule 10b-5 of the Securities Exchange Act of 1934 (the “Exchange Act”), 15
`
`U.S.C. § 78a et seq., as to public statements relating to two drugs in Celgene’s new product
`
`pipeline. Currently pending before the Court is Defendants’ motion to dismiss Plaintiffs’
`
`Complaint for failure to state a claim pursuant to Federal Rule of Civil Procedure 12(b)(6), as well
`
`as the Private Securities Litigation Reform Act of 1995 (“PSLRA”), 15 U.S.C. § 78u et seq. D.E.
`
`

`

`Case 2:20-cv-03754-JMV-JBC Document 18 Filed 03/22/21 Page 2 of 23 PageID: 1499
`
`6. The Court reviewed the parties’ submissions in support and in opposition,1 and decided the
`
`motion without oral argument pursuant to Fed. R. Civ. P. 78(b) and L. Civ. R. 78.1(b). For the
`
`reasons stated below, Defendants’ motion is GRANTED in part and DENIED in part.
`
`I.
`
`INTRODUCTION
`
`A. Background
`
`Plaintiffs’ allegations here mirror those pled in the Class Action. In fact, the vast majority
`
`of Plaintiffs’ Complaint is copied from the operative Complaint in the Class Action (the “Class
`
`Action Complaint”). As a result, the Court incorporates the detailed factual background from its
`
`December 19, 2019 Opinion that granted in part and denied in part the motion to dismiss the Class
`
`Action Complaint, D.E. 75, into the present Opinion.
`
`
`
`Briefly, Celgene manufactures and sells the multiple myeloma drug Revlimid, which
`
`between 2014 and 2016, accounted for more than sixty percent of Celgene’s total net sales.2
`
`Compl. ¶ 1. The Revlimid patent expires in 2022. Id. Plaintiffs allege that Defendants3 made
`
`
`1 Defendants’ moving brief will be referred to as “Defs. Br.,” D.E. 6-1; Plaintiffs’ opposition will
`be referred to as “Plfs. Opp,” D.E. 10; and Defendants’ reply will be referred to as “Defs. Reply,”
`D.E. 17.
`
` 2
`
` The facts are derived from Plaintiffs’ Complaint. D.E. 1. When reviewing a Rule 12(b)(6)
`motion to dismiss, the Court accepts as true all well-pleaded facts in the complaint. Fowler v.
`UPMC Shadyside, 578 F.3d 203, 210 (3d Cir. 2009). Additionally, a district court may consider
`“exhibits attached to the complaint and matters of public record,” as well as “an undisputedly
`authentic document that a defendant attaches as an exhibit to a motion to dismiss if the plaintiff’s
`claims are based on the document.” Pension Ben. Guar. Corp. v. White Consol. Indus., Inc., 998
`F.2d 1192, 1196 (3d Cir. 1993).
`
` 3
`
` The defendants in this matter are Celgene; Scott A. Smith, Celgene’s President and Chief
`Operating Officer from April 1, 2017 until April 2, 2018, Compl. ¶ 52; Terrie Curran, President of
`the Global Inflammatory & Immunology (“I&I”) franchise during the time frame at issue, id. ¶ 53;
`and Philippe Martin, Managing Director of Receptos and Celgene’s Corporate Vice President
`during the relevant time frame, id. ¶ 54.
`
`
`
`2
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket